Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Immuneering (IMRX) EBT Margin (2020 - 2022)

Immuneering's EBT Margin history spans 3 years, with the latest figure at 2960184.4% for Q4 2022.

  • On a quarterly basis, EBT Margin fell 295439674.0% to 2960184.4% in Q4 2022 year-over-year; TTM through Sep 2023 was 11588326.59%, a 1157879575.0% decrease, with the full-year FY2022 number at 15937.29%, down 1431018.0% from a year prior.
  • EBT Margin came in at 2960184.4% for Q4 2022, down from 33781.04% in the prior quarter.
  • The five-year high for EBT Margin was 644.49% in Q3 2020, with the low at 2960184.4% in Q4 2022.
  • Historically, EBT Margin has averaged 274998.48% across 3 years, with a median of 1768.4% in 2021.
  • Biggest five-year swings in EBT Margin: plummeted -46062bps in 2021 and later plummeted -295439674bps in 2022.
  • Year by year, EBT Margin stood at 877.48% in 2020, then crashed by -560bps to 5787.65% in 2021, then tumbled by -51047bps to 2960184.4% in 2022.
  • Business Quant data shows EBT Margin for IMRX at 2960184.4% in Q4 2022, 33781.04% in Q3 2022, and 12183.19% in Q2 2022.